Global Intravitreal Injectable Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Intravitreal Injectable Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

According to APO Research, The global Intravitreal Injectable market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Intravitreal Injectable is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Intravitreal Injectable is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Intravitreal Injectable is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Intravitreal Injectable include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech and Kanghong Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope


This report aims to provide a comprehensive presentation of the global market for Intravitreal Injectable, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravitreal Injectable.
The Intravitreal Injectable market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravitreal Injectable market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical
Intravitreal Injectable segment by Drug
Anti-VEGF
Steroids
Others
Intravitreal Injectable segment by Disease
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others
Intravitreal Injectable Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers


High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravitreal Injectable market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Intravitreal Injectable and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravitreal Injectable.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intravitreal Injectable manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Intravitreal Injectable in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Intravitreal Injectable Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Intravitreal Injectable Sales Estimates and Forecasts (2019-2030)
1.3 Intravitreal Injectable Market by Drug
1.3.1 Anti-VEGF
1.3.2 Steroids
1.3.3 Others
1.4 Global Intravitreal Injectable Market Size by Drug
1.4.1 Global Intravitreal Injectable Market Size Overview by Drug (2019-2030)
1.4.2 Global Intravitreal Injectable Historic Market Size Review by Drug (2019-2024)
1.4.3 Global Intravitreal Injectable Forecasted Market Size by Drug (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Intravitreal Injectable Sales Breakdown by Drug (2019-2024)
1.5.2 Europe Intravitreal Injectable Sales Breakdown by Drug (2019-2024)
1.5.3 Asia-Pacific Intravitreal Injectable Sales Breakdown by Drug (2019-2024)
1.5.4 Latin America Intravitreal Injectable Sales Breakdown by Drug (2019-2024)
1.5.5 Middle East and Africa Intravitreal Injectable Sales Breakdown by Drug (2019-2024)
2 Global Market Dynamics
2.1 Intravitreal Injectable Industry Trends
2.2 Intravitreal Injectable Industry Drivers
2.3 Intravitreal Injectable Industry Opportunities and Challenges
2.4 Intravitreal Injectable Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Intravitreal Injectable Revenue (2019-2024)
3.2 Global Top Players by Intravitreal Injectable Sales (2019-2024)
3.3 Global Top Players by Intravitreal Injectable Price (2019-2024)
3.4 Global Intravitreal Injectable Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Intravitreal Injectable Key Company Manufacturing Sites & Headquarters
3.6 Global Intravitreal Injectable Company, Product Type & Application
3.7 Global Intravitreal Injectable Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Intravitreal Injectable Market CR5 and HHI
3.8.2 Global Top 5 and 10 Intravitreal Injectable Players Market Share by Revenue in 2023
3.8.3 2023 Intravitreal Injectable Tier 1, Tier 2, and Tier 3
4 Intravitreal Injectable Regional Status and Outlook
4.1 Global Intravitreal Injectable Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Intravitreal Injectable Historic Market Size by Region
4.2.1 Global Intravitreal Injectable Sales in Volume by Region (2019-2024)
4.2.2 Global Intravitreal Injectable Sales in Value by Region (2019-2024)
4.2.3 Global Intravitreal Injectable Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Intravitreal Injectable Forecasted Market Size by Region
4.3.1 Global Intravitreal Injectable Sales in Volume by Region (2025-2030)
4.3.2 Global Intravitreal Injectable Sales in Value by Region (2025-2030)
4.3.3 Global Intravitreal Injectable Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Intravitreal Injectable by Application
5.1 Intravitreal Injectable Market by Disease
5.1.1 Macular Degeneration
5.1.2 Macular Edema
5.1.3 Uveitis
5.1.4 Retinal Vein Occlusion
5.1.5 Others
5.2 Global Intravitreal Injectable Market Size by Disease
5.2.1 Global Intravitreal Injectable Market Size Overview by Application (2019-2030)
5.2.2 Global Intravitreal Injectable Historic Market Size Review by Application (2019-2024)
5.2.3 Global Intravitreal Injectable Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Disease
5.3.1 North America Intravitreal Injectable Sales Breakdown by Disease (2019-2024)
5.3.2 Europe Intravitreal Injectable Sales Breakdown by Disease (2019-2024)
5.3.3 Asia-Pacific Intravitreal Injectable Sales Breakdown by Disease (2019-2024)
5.3.4 Latin America Intravitreal Injectable Sales Breakdown by Disease (2019-2024)
5.3.5 Middle East and Africa Intravitreal Injectable Sales Breakdown by Disease (2019-2024)
6 Company Profiles
6.1 Regeneron Pharmaceuticals (Eylea)
6.1.1 Regeneron Pharmaceuticals (Eylea) Comapny Information
6.1.2 Regeneron Pharmaceuticals (Eylea) Business Overview
6.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Portfolio
6.1.5 Regeneron Pharmaceuticals (Eylea) Recent Developments
6.2 Allergan
6.2.1 Allergan Comapny Information
6.2.2 Allergan Business Overview
6.2.3 Allergan Intravitreal Injectable Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Allergan Intravitreal Injectable Product Portfolio
6.2.5 Allergan Recent Developments
6.3 EyePoint Pharmaceuticals
6.3.1 EyePoint Pharmaceuticals Comapny Information
6.3.2 EyePoint Pharmaceuticals Business Overview
6.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Sales, Revenue and Gross Margin (2019-2024)
6.3.4 EyePoint Pharmaceuticals Intravitreal Injectable Product Portfolio
6.3.5 EyePoint Pharmaceuticals Recent Developments
6.4 Genentech
6.4.1 Genentech Comapny Information
6.4.2 Genentech Business Overview
6.4.3 Genentech Intravitreal Injectable Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Genentech Intravitreal Injectable Product Portfolio
6.4.5 Genentech Recent Developments
6.5 Kanghong Pharmaceutical
6.5.1 Kanghong Pharmaceutical Comapny Information
6.5.2 Kanghong Pharmaceutical Business Overview
6.5.3 Kanghong Pharmaceutical Intravitreal Injectable Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kanghong Pharmaceutical Intravitreal Injectable Product Portfolio
6.5.5 Kanghong Pharmaceutical Recent Developments
7 North America by Country
7.1 North America Intravitreal Injectable Sales by Country
7.1.1 North America Intravitreal Injectable Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Intravitreal Injectable Sales by Country (2019-2024)
7.1.3 North America Intravitreal Injectable Sales Forecast by Country (2025-2030)
7.2 North America Intravitreal Injectable Market Size by Country
7.2.1 North America Intravitreal Injectable Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Intravitreal Injectable Market Size by Country (2019-2024)
7.2.3 North America Intravitreal Injectable Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Intravitreal Injectable Sales by Country
8.1.1 Europe Intravitreal Injectable Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Intravitreal Injectable Sales by Country (2019-2024)
8.1.3 Europe Intravitreal Injectable Sales Forecast by Country (2025-2030)
8.2 Europe Intravitreal Injectable Market Size by Country
8.2.1 Europe Intravitreal Injectable Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Intravitreal Injectable Market Size by Country (2019-2024)
8.2.3 Europe Intravitreal Injectable Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Intravitreal Injectable Sales by Country
9.1.1 Asia-Pacific Intravitreal Injectable Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Intravitreal Injectable Sales by Country (2019-2024)
9.1.3 Asia-Pacific Intravitreal Injectable Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Intravitreal Injectable Market Size by Country
9.2.1 Asia-Pacific Intravitreal Injectable Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Intravitreal Injectable Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Intravitreal Injectable Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Intravitreal Injectable Sales by Country
10.1.1 Latin America Intravitreal Injectable Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Intravitreal Injectable Sales by Country (2019-2024)
10.1.3 Latin America Intravitreal Injectable Sales Forecast by Country (2025-2030)
10.2 Latin America Intravitreal Injectable Market Size by Country
10.2.1 Latin America Intravitreal Injectable Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Intravitreal Injectable Market Size by Country (2019-2024)
10.2.3 Latin America Intravitreal Injectable Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Intravitreal Injectable Sales by Country
11.1.1 Middle East and Africa Intravitreal Injectable Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Intravitreal Injectable Sales by Country (2019-2024)
11.1.3 Middle East and Africa Intravitreal Injectable Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Intravitreal Injectable Market Size by Country
11.2.1 Middle East and Africa Intravitreal Injectable Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Intravitreal Injectable Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Intravitreal Injectable Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Intravitreal Injectable Value Chain Analysis
12.1.1 Intravitreal Injectable Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Intravitreal Injectable Production Mode & Process
12.2 Intravitreal Injectable Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Intravitreal Injectable Distributors
12.2.3 Intravitreal Injectable Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings